These Are the Top Pediatric Care Providers in Westchester

Image
vaccine finder near me :: Article Creator Where Can I Find The New COVID Vaccine Near Me? - KQED Where Can I Find the New COVID Vaccine Near Me?KQEDKQEDSave ArticleKQEDKQED News News Daily Newsletter Stay on top of what's happening in the Bay Area with essential Bay Area news stories, sent to your inbox every weekday. Podcasts & Radio Hyphenación Where conversation and cultura meet. Video & TV Meredith's Must-Sees See Senior Director of TV Programming Meredith Speight's recommendations from this month's KQED 9, PLUS and Passport schedules. Events Videos from KQED Live Watch recordings of recent KQED Live events. Support KQED Donor-Advised Funds Support KQED by using your donor-advised fund to make a charitable gift. Featured ...

Study: Moving HPV vaccine initiation to age 9 or 10 could improve ... - Healio

February 28, 2023

2 min read

Source/Disclosures

Disclosures: Goodman is employed by Merck. Please see the study for all other authors' relevant financial disclosures.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Routine HPV vaccination rates could be improved if children were vaccinated earlier, according to a new study.

The CDC recommends routine HPV vaccination in the U.S. at ages 11 or 12 years but says the vaccine can be given as early as age 9 years.

IDC0223Goodman_Graphic_01

Elizabeth Goodman, MD, MBA, a researcher at Merck's Center for Observational and Real-World Evidence, told Healio that she and her colleagues studied whether or not initiating HPV vaccination at ages 9 to 10 years had a positive impact on the HPV series completion when compared with initiation at ages 11 to 12 years.

"Completion rates among young people in the U.S. have remained stubbornly suboptimal — 61.7% among 13- to 17-year-olds in 2021, well below the Healthy People 2020 target of 80%," Goodman said. "Any action resulting in higher completion rates before HPV exposure and infection has the potential to increase the public health benefits of vaccination. Since the likelihood of HPV exposure increases as adolescents age, the goal is to vaccinate children prior to HPV exposure."

Goodman and colleagues assessed data from the National Immunization Survey-Teen 2017-2020, comprising 19,575 15- to 17-year-olds who initiated HPV vaccination between the ages of 9 to 12 years.

Ultimately, early initiators were more likely to complete the vaccination series by ages 13 (74% vs. 31.1%, P < .001) and 15 (91.7% vs. 82.7%, P < .001) years but less likely to complete within 3 years (82.3% v.s 84.9%, P = .007).

According to Goodman, although the researchers did not have "specific expectations" for what the study would show, they hypothesized that earlier age of initiation would lead to stronger series completion rates in early and mid-adolescence.

"The findings suggest this is because of increased time between initiation and the target completion age, what we called the 'time pathway' in the paper," Goodman said. "We had thought that, in addition to the time pathway, changing the developmental stage by moving initiation from early adolescence, or ages 11 to 12 years, to late childhood, or ages 9 to 10 years, what we called the 'development pathway,' would be one way that earlier initiation could impact completion, but the data did not support that mechanism of action."

The researchers ultimately concluded that moving HPV vaccination recommendations to age 9 and 10 could improve coverage rates.

"While more research is needed in this area, this study provides physicians with helpful information as they consider when to begin discussing HPV vaccination," Goodman said. "We are always interested in additional research that might help inform the scientific community on the potential impact of HPV vaccination to both individual and public health."

Comments

Popular posts from this blog

Primary Care - North Greece Internal Medicine & Pediatrics

180+ chief medical officers to know | 2025

Screening and Testing for Hepatitis B Virus Infection ...